{"brief_title": "Safety and Tolerability Study of Drug to Treat Schizophrenia", "brief_summary": "The purpose of this study is to evaluate the long-term safety of SM-13496 in patients with schizophrenia.", "condition": "Schizophrenia", "intervention_type": "Drug", "intervention_name": "Lurasidone 80mg", "description": "Lurasidone 80mg oral tablet taken once daily", "arm_group_label": "Lurasidone 80mg", "criteria": "Inclusion criteria: - Successful completion of participation in protocol #D1050049 Exclusion criteria: - Substance abuse - Prolactin level of \u2265200ng/mL at baseline - Pregnancy", "gender": "All", "minimum_age": "18 Years", "maximum_age": "65 Years", "healthy_volunteers": "No", "id": "NCT00044005.xml"}